NEW YORK (GenomeWeb) – OncoDNA said today that it signed a distribution agreement with Providens to market and distribute its cancer genomic tests to oncologists and their patients in Croatia, Bosnia-Herzegovina, Slovenia, Serbia, Montenegro, and Macedonia.

Providens will give physicians in the region access to OncoDNA's molecular profiling technology, which combines analysis of liquid and solid biopsies for patients with metastatic cancer, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.